Export Snapshot

Minimum order

1 Centimetre

HSN Code

On request

Origin

India

Lead time

On request

Port of dispatch

On request

Packaging

Standard export packaging

Shelf life / storage

As per product specification

Export markets served

DZ AD AI AO AR +47 others

Ability to customise

As per OEM brief

Values shown are for Melizza Lifescience.

Company Melizza Lifescience

Melizza Lifescience

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals › Drugs & Pharmaceuticals.

View profile →

Established

Not shared

Employees

–

GST

24GQFPM5460R1Z4

IEC code

GQFPM5460R

Export markets

DZ AD AI AO AR +47 others

Member since

Aug 2025

Turnover

On request

Incorporation type

On request

Product details

Dosage & Administration:

• Administered by intravenous infusion only under hospital/ICU settings.

• Standard adult dose for AMI: 1.5 million IU infused over 60 minutes.

• Dosage may vary based on indication and patient condition.

(To be given by trained healthcare professionals only.)

Key Benefits:

• Rapid clot dissolution in life-threatening conditions.

• Reduces risk of mortality in acute heart attack patients.

• Restores blood flow and prevents tissue necrosis.

Packaging:

• Vial containing 15,00,000 IU Streptokinase with sterile diluent.

Storage:

• Store at 2°C – 8°C (Refrigerated).

• Protect from light.

• Do not freeze.

Important Notes:

• For hospital use under strict medical supervision only.

• Contraindicated in patients with active internal bleeding, recent stroke, severe hypertension, or history of hemorrhagic disorders.

• Close monitoring of blood pressure, ECG, and bleeding parameters is mandatory.

Description provided by Melizza Lifescience.

Streptokinase 1.5 Million IU

Thrombolytic Agent / Cardiovascular Medicine

Acute Myocardial Infarction, Pulmonary Embolism, Deep Vein Thrombosis, Arterial Thromboembolism, Occluded Arteriovenous Cannulae

Injectable solution for intravenous infusion

1.5 million IU infused over 60 minutes

Activates plasminogen to plasmin to dissolve fibrin clots

Vial containing Streptokinase with sterile diluent

Refrigerate at 2°C – 8°C, protect from light, do not freeze

Hospital / ICU use only by trained professionals

Requires monitoring of blood pressure, ECG, and bleeding parameters

Specifications

Product Type

Injection

Active Substance

Streptokinase

IU Strength

1,500,000 IU

Therapeutic Use

Thrombolytic for clot dissolution

Route of Administration

Intravenous infusion

Indications Specificity

AMI, PE, DVT, Arterial Thrombosis, AV Cannulae occlusion

Dosage

1.5 million IU over 60 minutes (standard for AMI)

Packaging Details

Single vial with sterile diluent

Storage

2°C – 8°C, no freezing, shield from light

Contraindications

Active internal bleeding, recent stroke, severe hypertension, hemorrhagic disorders

Professional Use

Strict medical supervision in hospital settings

Use cases

Category

Pharmaceuticals > Cardiovascular Drugs > Thrombolytic Agents > Streptokinase Injections

Primary application

Brand

Not specified

Product type

Product

Logistics & handling

Lead time

On request

Packaging

As per buyer requirement

Storage condition

As recommended by supplier

Origin

India

Form

As listed by supplier

Commercials Melizza Lifescience

Minimum order

1 Centimetre

Lead time

On request

Payment terms

As per negotiated commercial agreement

Frequently asked by buyers

What is the recommended administration protocol for ICIKINASE 1,500,000 IU Injection in AMI patients?

ICIKINASE is administered via intravenous infusion over 60 minutes, with a standard dose of 1.5 million IU, under strict medical supervision in hospital or ICU settings.

Are there any contraindications for using ICIKINASE in thrombolytic therapy?

Yes, it is contraindicated in patients with active internal bleeding, recent stroke, severe hypertension, or hemorrhagic disorders to avoid bleeding complications.

How should ICIKINASE Injection be stored to maintain its efficacy?

Store the vial refrigerated between 2°C and 8°C, protect from light exposure, and do not freeze to ensure the stability and potency of the medication.

Can ICIKINASE be used for clearing occluded arteriovenous cannulae?

Yes, ICIKINASE is indicated for dissolving clots in occluded arteriovenous cannulae, facilitating restoration of patency.

What monitoring is required during ICIKINASE administration?

Continuous monitoring of blood pressure, electrocardiogram (ECG), and bleeding parameters is mandatory to manage therapeutic safety during thrombolysis.

Question not answered? Sellers typically reply within 24–48 hours. Ask a question

What similar products are available in this category?

Browse all →

GST VERIFIED

montrelief lc tab - dr precision

Bluepill Express

From $ 1.18

MOQ 1 Piece

GST VERIFIED

montrelief fx tab - dr precision

Bluepill Express

From $ 2.09

MOQ 1 Piece

GST VERIFIED

modvigil 200 tab - dr precision

Bluepill Express

From $ 5.21

MOQ 1 Piece

GST VERIFIED

gabasign 800 cap - dr precision

Bluepill Express

From $ 19.55

MOQ 1 Piece

GST VERIFIED

gabasign 600 cap - dr precision

Bluepill Express

From $ 14.34

MOQ 1 Piece

GST VERIFIED

gabasign 400 cap - dr precision

Bluepill Express

From $ 3.00

MOQ 1 Piece

GST VERIFIED

epivalprate 200tab - dr precision

Bluepill Express

From $ 2.04

MOQ 1 Piece

GST VERIFIED

cid-0-rab dsr tab - dr precision

Bluepill Express

From $ 1.44

MOQ 1 Piece

More from Melizza Lifescience